Delivers clinically validated results for many patients, from post-weight-loss care to anti-aging treatments
The purported health benefits now appear to be even more far-reaching, with the latest data from a trial called Select, published in 2023, showing that semaglutide can slash the risk of heart attacks and strokes by a fifth in patients with an existing history of cardiovascular disease
The production of the first functional antibody mimetic in higher plants: The chloroplast makes the DARPin G3 for HER2 imaging in oncology
Importantly, the ECD of GLP-1R undergoes a remarkable orientation change from the closed TMD-interacting conformation to the extended active conformation during peptide binding and activation
In one study, participants using Semaglutide alongside lifestyle changes lost an average of 15% of their body weight over 68 weeks
J Endocrinol (2009) 202(3):4319